Engineers Gate Manager LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 304 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2023$176,385
-25.8%
10,703
-29.8%
0.01%
-50.0%
Q4 2022$237,838
+34.4%
15,246
+11.9%
0.01%
+27.3%
Q3 2022$177,000
-57.3%
13,625
-53.9%
0.01%
-26.7%
Q2 2022$415,000
+87.8%
29,579
+91.3%
0.02%
+66.7%
Q1 2022$221,000
-34.8%
15,462
-37.9%
0.01%
-40.0%
Q4 2021$339,000
+36.7%
24,885
+83.0%
0.02%
+25.0%
Q1 2021$248,000
+7.4%
13,600
+5.4%
0.01%0.0%
Q2 2020$231,00012,8990.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders